Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3729075
Max Phase: Preclinical
Molecular Formula: C24H25ClFN3O2
Molecular Weight: 441.93
Molecule Type: Small molecule
Associated Items:
ID: ALA3729075
Max Phase: Preclinical
Molecular Formula: C24H25ClFN3O2
Molecular Weight: 441.93
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ncc(Cl)cc1C(=O)N[C@H]1CC[C@H](CN2C(=O)C3(CC3)c3cc(F)ccc32)CC1
Standard InChI: InChI=1S/C24H25ClFN3O2/c1-14-19(10-16(25)12-27-14)22(30)28-18-5-2-15(3-6-18)13-29-21-7-4-17(26)11-20(21)24(8-9-24)23(29)31/h4,7,10-12,15,18H,2-3,5-6,8-9,13H2,1H3,(H,28,30)/t15-,18-
Standard InChI Key: IMAXYSCPKOIFBE-RZDIXWSQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 441.93 | Molecular Weight (Monoisotopic): 441.1619 | AlogP: 4.55 | #Rotatable Bonds: 4 |
Polar Surface Area: 62.30 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.97 | CX Basic pKa: 2.68 | CX LogP: 3.53 | CX LogD: 3.53 |
Aromatic Rings: 2 | Heavy Atoms: 31 | QED Weighted: 0.76 | Np Likeness Score: -1.29 |
1. (2011) Cyclohexyl amide derivatives as CRF receptor antagonists, |
Source(1):